Last update 20 Mar 2025

Dimdazenil

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
安达西尼
+ [1]
Action
positive allosteric modulator
Mechanism
GABAA receptor positive allosteric modulator(Gamma-aminobutyric acid A receptor positive allosteric modulator)
Therapeutic Areas
Inactive Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
RegulationSpecial Review Project (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC17H17ClN6O2
InChIKeyJCYLWUVDHLVGER-UHFFFAOYSA-N
CAS Registry308239-86-3

External Link

KEGGWikiATCDrug Bank
-Dimdazenil-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Sleep Initiation and Maintenance Disorders
China
28 Nov 2023
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SleepinessPhase 1
United States
01 Nov 2006
Sleep Initiation and Maintenance DisordersPhase 1
United States
01 Sep 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
50
Dimdazenil 1.5 mg (single dose)
(onwvwauslv) = In the range of 0.5-1.5 h. kjlngerhdl (wcxohstkqt )
Positive
01 Aug 2023
Dimdazenil 2.5 mg (single dose)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free